News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
546,818 Results
Type
Article (55223)
Company Profile (154)
Press Release (491441)
Section
Business (152881)
Career Advice (1806)
Deals (25367)
Drug Delivery (78)
Drug Development (69181)
Employer Resources (135)
FDA (12574)
Job Trends (12274)
News (263299)
Policy (24763)
Tag
Academia (2783)
Alliances (42702)
Alzheimer's disease (1253)
Approvals (12540)
Artificial intelligence (138)
Bankruptcy (186)
Best Places to Work (9859)
Biotechnology (109)
Breast cancer (194)
Cancer (1427)
Cardiovascular disease (103)
Career advice (1510)
CAR-T (101)
Cell therapy (308)
Clinical research (54579)
Collaboration (526)
Compensation (158)
COVID-19 (2387)
C-suite (121)
Data (1352)
Diabetes (157)
Diagnostics (5318)
Earnings (54478)
Employer resources (119)
Events (74614)
Executive appointments (409)
FDA (13256)
Funding (475)
Gene therapy (201)
GLP-1 (533)
Government (4021)
Healthcare (15716)
Infectious disease (2473)
Inflammatory bowel disease (106)
Interviews (338)
IPO (12164)
Job creations (2811)
Job search strategy (1290)
Layoffs (339)
Legal (4190)
Lung cancer (219)
Manufacturing (204)
Medical device (10295)
Medtech (10299)
Mergers & acquisitions (13479)
Metabolic disorders (419)
Neuroscience (1568)
NextGen: Class of 2025 (5148)
Non-profit (4261)
Northern California (1556)
Obesity (229)
Opinion (182)
Patents (106)
People (45200)
Phase I (17326)
Phase II (23855)
Phase III (18114)
Pipeline (531)
Postmarket research (2206)
Preclinical (7940)
Radiopharmaceuticals (228)
Rare diseases (253)
Real estate (5012)
Regulatory (17981)
Research institute (2563)
Resumes & cover letters (271)
Southern California (1335)
Startups (2918)
United States (13753)
Vaccines (531)
Weight loss (154)
Date
Today (17)
Last 7 days (729)
Last 30 days (1648)
Last 365 days (30404)
2025 (807)
2024 (30921)
2023 (35042)
2022 (45588)
2021 (48860)
2020 (46027)
2019 (38643)
2018 (28946)
2017 (27048)
2016 (25944)
2015 (30363)
2014 (23010)
2013 (19945)
2012 (20281)
2011 (20904)
2010 (19178)
Location
Africa (709)
Arizona (112)
Asia (33321)
Australia (5890)
California (3463)
Canada (1314)
China (317)
Colorado (145)
Connecticut (174)
Europe (77186)
Florida (517)
Georgia (113)
Illinois (336)
Indiana (200)
Maryland (613)
Massachusetts (2647)
Michigan (170)
Minnesota (208)
New Jersey (1013)
New York (1048)
North Carolina (699)
Northern California (1556)
Ohio (137)
Pennsylvania (809)
South America (914)
Southern California (1335)
Texas (519)
Utah (98)
Washington State (385)
546,818 Results for "defense advanced research projects agency darpa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments
Ginkgo Bioworks announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency to achieve DARPA’s objectives under its new Ice Control for cold Environments program.
March 28, 2024
·
6 min read
BioCapital
Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
The Defense Advanced Research Projects Agency ( DARPA ) announced that Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has been awarded a 4-year contract worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.
July 19, 2023
·
7 min read
Lone Star Bio
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
TFF Pharmaceuticals, Inc. today announced that the government will be advancing several next-generation medical countermeasures (MCMs) formulated with its Thin Film Freezing technology into advanced preclinical testing.
May 23, 2024
·
5 min read
Policy
Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health’s Advanced Research Projects Agency for Health (ARPA-H)
Thymmune Therapeutics announced that the U.S. Department of Health and Human Services, through the Advanced Research Projects Agency for Health has awarded up to $37 million in funding to the Thymus Rejuvenation project.
September 29, 2023
·
3 min read
Press Releases
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
October 17, 2024
·
7 min read
Press Releases
NCCN Announces Funding for a Prostate Cancer Research Project
December 11, 2024
·
3 min read
Business
Primmune Therapeutics Secures $22.5 Million Contract from Defense Threat Reduction Agency (DTRA) to Advance PRTX007 for Treatment of Lassa Fever
Primmune Therapeutics today announced that it was awarded a $22,480,552 contract by the Defense Threat Reduction Agency (DTRA) to develop PRTX007 as an oral broad spectrum antiviral TLR7 agonist for the treatment of Lassa fever.
March 20, 2024
·
4 min read
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
Tonix Pharmaceuticals Holding Corp. announced it has been awarded an Other Transaction Agreement with a potential for up to $34 million over five years by the Defense Threat Reduction Agency, an agency within the U.S. Department of Defense.
July 1, 2024
·
7 min read
TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research
TILT Biotherapeutics announces it has been selected by the U.S. Department of Defense, America’s largest government agency, to receive a USD 2M grant for a three-year project on treatment for ovarian cancer using the company’s TILT-123 asset.
February 14, 2024
·
4 min read
Press Releases
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
·
6 min read
1 of 54,682
Next
